These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 28741603)

  • 21. The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients.
    Kim HJ; Kim YS; Kim KH; Choi JP; Kim YK; Yun S; Sharma L; Dela Cruz CS; Lee JS; Oh YM; Lee SD; Lee SW
    Exp Mol Med; 2017 Apr; 49(4):e316. PubMed ID: 28408748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
    Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE
    Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial microbiome of lungs in COPD.
    Sze MA; Hogg JC; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2014; 9():229-38. PubMed ID: 24591822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The lung microbiome in moderate and severe chronic obstructive pulmonary disease.
    Pragman AA; Kim HB; Reilly CS; Wendt C; Isaacson RE
    PLoS One; 2012; 7(10):e47305. PubMed ID: 23071781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
    Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
    PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
    Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
    F1000Res; 2023; 12():528. PubMed ID: 37928173
    [No Abstract]   [Full Text] [Related]  

  • 27. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.
    Garcia-Nuñez M; Millares L; Pomares X; Ferrari R; Pérez-Brocal V; Gallego M; Espasa M; Moya A; Monsó E
    J Clin Microbiol; 2014 Dec; 52(12):4217-23. PubMed ID: 25253795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study.
    Chen YF; Hou HH; Chien N; Lu KZ; Lin CH; Liao YC; Lor KL; Chien JY; Chen CM; Chen CY; Cheng SL; Wang HC; Hsueh PR; Yu CJ
    Respir Res; 2024 Aug; 25(1):308. PubMed ID: 39143556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease.
    Pragman AA; Lyu T; Baller JA; Gould TJ; Kelly RF; Reilly CS; Isaacson RE; Wendt CH
    Microbiome; 2018 Jan; 6(1):7. PubMed ID: 29316977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
    Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the lung microbiome in the "healthy" smoker and in COPD.
    Erb-Downward JR; Thompson DL; Han MK; Freeman CM; McCloskey L; Schmidt LA; Young VB; Toews GB; Curtis JL; Sundaram B; Martinez FJ; Huffnagle GB
    PLoS One; 2011 Feb; 6(2):e16384. PubMed ID: 21364979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.
    Tangedal S; Nielsen R; Aanerud M; Persson LJ; Wiker HG; Bakke PS; Hiemstra PS; Eagan TM
    PLoS One; 2019; 14(9):e0222449. PubMed ID: 31527888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions.
    Huang YJ; Erb-Downward JR; Dickson RP; Curtis JL; Huffnagle GB; Han MK
    Transl Res; 2017 Jan; 179():71-83. PubMed ID: 27392936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchial microbiome, PA biofilm-forming capacity and exacerbation in severe COPD patients colonized by P. aeruginosa.
    Garcia-Nuñez M; Marti S; Puig C; Perez-Brocal V; Millares L; Santos S; Ardanuy C; Moya A; Liñares J; Monsó E
    Future Microbiol; 2017 Apr; 12():379-392. PubMed ID: 28339291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The bronchial epithelial cell bacterial microbiome and host response in patients infected with human immunodeficiency virus.
    Sze MA; Xu S; Leung JM; Vucic EA; Shaipanich T; Moghadam A; Harris M; Guillemi S; Sinha S; Nislow C; Murphy D; Hague C; Leipsic J; Lam S; Lam W; Montaner JS; Sin DD; Man SF
    BMC Pulm Med; 2016 Nov; 16(1):142. PubMed ID: 27829448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males.
    Lee SW; Kuan CS; Wu LS; Weng JT
    PLoS One; 2016; 11(7):e0159066. PubMed ID: 27428540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sputum microbiome profiling in COPD: beyond singular pathogen detection.
    Ditz B; Christenson S; Rossen J; Brightling C; Kerstjens HAM; van den Berge M; Faiz A
    Thorax; 2020 Apr; 75(4):338-344. PubMed ID: 31996401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
    Wang Z; Singh R; Miller BE; Tal-Singer R; Van Horn S; Tomsho L; Mackay A; Allinson JP; Webb AJ; Brookes AJ; George LM; Barker B; Kolsum U; Donnelly LE; Belchamber K; Barnes PJ; Singh D; Brightling CE; Donaldson GC; Wedzicha JA; Brown JR;
    Thorax; 2018 Apr; 73(4):331-338. PubMed ID: 29269441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The microbiome in respiratory medicine: current challenges and future perspectives.
    Faner R; Sibila O; Agustí A; Bernasconi E; Chalmers JD; Huffnagle GB; Manichanh C; Molyneaux PL; Paredes R; Pérez Brocal V; Ponomarenko J; Sethi S; Dorca J; Monsó E
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sputum Microbiome Dynamics in Chronic Obstructive Pulmonary Disease Patients during an Exacerbation Event and Post-Stabilization.
    López Caro JC; Santibáñez M; García Rivero JL; Villanueva M; Sainz J; González Astorqui P; Hierro M; Rodríguez Porres M; Paras Bravo P; Mira A; Rodriguez JC; Galiana A;
    Respiration; 2019; 98(5):447-454. PubMed ID: 31437842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.